SEATTLE-November 16, 2022 -(BUSINESS WIRE)–Curevo Vaccine (Curevo), a privately held clinical-stage biotechnology company dedicated to reducing the burden of infectious disease by developing safe and highly-effective vaccines, today announced the closing of a $26 million Series A1 financing round. This brings total funding raised in 2022 to $86M for the…Read More
“Trinitas Partners contacted FLG several years ago as we were rapidly expanding our funds and investment portfolio. We were looking for assistance in build our long-term strategic plans, as well as perform an assessment of our finance team so that we would be able to handle our anticipated growth and effectively manage our funds and the investment properties. Our FLG partner helped us to achieve this and help develop our finance team over the past several years. We would strongly recommend FLG to any firm looking for experienced financial guidance and leadership to help in a period of rapid growth.”
Bill Hooper, Principal, Trinitas Partners LLC Read More
